COMMD9 Antibody (04) [DyLight 755]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-06601IR
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA, Immunocytochemistry/ Immunofluorescence
Label
DyLight 755 (Excitation = 754 nm, Emission = 776 nm)
Antibody Source
Monoclonal Mouse IgG2A Clone # 04
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human COMMD9 (Uniprot#: Q9P000-1; Met1-Lys198).
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2A
Applications for COMMD9 Antibody (04) [DyLight 755]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: COMMD9
Alternate Names
COMM domain containing 9, COMM domain-containing protein 9, COMM9, FLJ31106, HSPC166
Gene Symbol
COMMD9
Additional COMMD9 Products
Product Documents for COMMD9 Antibody (04) [DyLight 755]
Product Specific Notices for COMMD9 Antibody (04) [DyLight 755]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...